Showing results (251-260 of 284) with videos related to

Sort By:
Pageof 29
Clinical and Experimental Immunology|July 2, 1998
Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell linesM A Nash, R Lenzi, C L Edwards, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Effects of interleukin-1 alpha on ovarian carcinoma in patients with recurrent diseaseC F Verschraegen, A P Kudelka, W Termrungruanglert, et al.
Cancer Treatment Reports|March 1, 1986
Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II studyR S Freedman, P B Saul, C L Edwards, et al.
American Journal of Clinical Oncology|June 1, 1989
Randomized comparison of viral oncolysate plus radiation and radiation alone in uterine cervix carcinomaR S Freedman, J M Bowen, E N Atkinson, et al.
Gynecologic Oncology|May 1, 1997
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescueK van Besien, C Verschraegen, R Mehra, et al.
Cancer Research|November 1, 1993
Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptorD G Kieback, S K McCamant, M F Press, et al.
Gynecologic Oncology|July 1, 1995
A trial of lobaplatin (D-19466) in platinum-resistant ovarian cancerJ J Kavanagh, C L Edwards, R S Freedman, et al.
Cancer|June 1, 1987
Intrahepatic infusional therapy for metastatic ovarian carcinomaJ M Malone, D M Gershenson, C H Carrasco, et al.
Gynecologic Oncology|November 1, 1993
Chicken ovalbumin upstream promoter transcription factor (COUP-TF): an orphan steroid receptor with a specific pattern of differential expression in human ovarian cancer cell linesD G Kieback, I B Runnebaum, V J Moebus, et al.
Anti-Cancer Drugs|March 10, 1998
A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitorC F Verschraegen, E A Natelson, B C Giovanella, et al.
Pageof 29